Cardiomyopathy in type 2 diabetes: Update on pathophysiological mechanisms

Justin Saunders, Shiny Mathewkutty, Mark H Drazner, Darren K McGuire

Research output: Contribution to journalReview articlepeer-review

39 Scopus citations


Type 2 diabetes mellitus (DM) is associated with increased risk for developing heart failure (HF) and worse outcomes once HF is present. While the exact mechanisms underpinning these observations remain poorly understood, several metabolic perturbations associated with DM have been implicated as contributors to the HF risk, including alterations of cardiomyocyte metabolic substrate switching between free fatty acid (FFA) and glucose metabolism; increased FFA exposure and cellular accumulation; and alterations in peroxisome proliferator-activated receptor-(PPAR-)α activity, among others. The commonly coincident conditions of left ventricular hypertrophy and ischemic heart disease likely confound the metabolic derangements further increasing HF risk. Continued investigation into these mechanistic connections is necessary to better understand the pathophysiology and ideally inform the pursuit of novel therapeutic targets and strategies to intervene on the HF associated with DM.

Original languageEnglish (US)
Pages (from-to)184-190
Number of pages7
Issue number3
StatePublished - Apr 1 2008


  • Diabetes
  • Free fatty acids
  • Heart failure
  • Hyperglycemia
  • Lipotoxicity
  • PPAR-α

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Cardiomyopathy in type 2 diabetes: Update on pathophysiological mechanisms'. Together they form a unique fingerprint.

Cite this